{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:55:33Z","timestamp":1790704533314,"version":"4.1.0"},"reference-count":140,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ijantimicag.2021.106380","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T03:25:07Z","timestamp":1624332307000},"page":"106380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8496-9446","authenticated-orcid":false,"given":"Vit\u00f3ria S.","family":"Foletto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taci\u00e9li F.","family":"da Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa B.","family":"Serafin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7168-7247","authenticated-orcid":false,"given":"Angelita","family":"Bottega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5513-4853","authenticated-orcid":false,"given":"Rosmari","family":"H\u00f6rner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2021.106380_bib0001","unstructured":"Centers for Disease Control and Prevention (CDC). Antibiotic use in the United States: progress and opportunities. 2017. https:\/\/www.cdc.gov\/antibiotic-use\/stewardship-report\/pdf\/stewardship-report.pdf [accessed 20 October 2020]."},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0002","unstructured":"World Health Organization (WHO). Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. 27 February 2017. https:\/\/www.who.int\/medicines\/publications\/global-priority-list-antibiotic-resistant-bacteria\/en \/[accessed 20 October 2020]."},{"issue":"4","key":"10.1016\/j.ijantimicag.2021.106380_bib0003","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1021\/acs.jmedchem.6b01439","article-title":"Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors","volume":"60","author":"Astolfi","year":"2017","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.ijantimicag.2021.106380_bib0004","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/bph.13895","article-title":"Drug repurposing screens and synergistic drug-combinations for infectious diseases","volume":"175","author":"Zheng","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0005","first-page":"01","article-title":"Study on Antimicrobial Potential of Selected Non-antibiotics and its Interaction with Conventional Antibiotics","volume":"6","author":"Hadera","year":"2018","journal-title":"K J Pharm Biosc"},{"issue":"1","key":"10.1016\/j.ijantimicag.2021.106380_bib0006","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1039\/C1MT00144B","article-title":"DNA, protein binding, cytotoxicity, cellular uptake and antibacterial activities of new palladium(II) complexes of thiosemicarbazone ligands: effects of substitution on biological activity","volume":"4","author":"Kalaivani","year":"2012","journal-title":"Metallomics"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0007","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.26694\/repis.v4i0.7350","article-title":"Resist\u00eancia Bacteriana \u00e0 Antibi\u00f3ticos na Unidade de Terapia Intensiva: Revis\u00e3o Integrativa","volume":"4","author":"Rodrigues","year":"2018","journal-title":"Rev Pre Infec e Sa\u00fade"},{"issue":"2","key":"10.1016\/j.ijantimicag.2021.106380_bib0008","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijep.2016.09.002","article-title":"Drug repositioning","volume":"3","author":"Mehndiratta","year":"2016","journal-title":"Int J Epilepsy"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0009","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bjid.2018.05.007","article-title":"Drug repositioning, a new alternative in infectious diseases","volume":"22","author":"Serafin","year":"2018","journal-title":"Braz J Inf Dis"},{"issue":"3","key":"10.1016\/j.ijantimicag.2021.106380_bib0010","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.bcp.2014.12.014","article-title":"Disulfiram-induced cytotoxicity and endo-lysosomal sequestration of zinc in breast cancer cells","volume":"93","author":"Wiggins","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0011","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4172\/2332-0877.1000292","article-title":"Novel Strategies to Combat Antimicrobial Resistance","volume":"4","author":"Kaur","year":"2016","journal-title":"J Infect Dis Ther"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"4","author":"Moher","year":"2015","journal-title":"Systematic Reviews"},{"issue":"3","key":"10.1016\/j.ijantimicag.2021.106380_bib0013","first-page":"71","article-title":"Anxiety and Depression: Optimizing Treatments","volume":"2","author":"Ballenger","year":"2020","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.ijantimicag.2021.106380_bib0014","doi-asserted-by":"crossref","first-page":"249","DOI":"10.31887\/DCNS.2003.5.3\/lstaner","article-title":"Sleep and anxiety disorders","volume":"5","author":"Staner","year":"2003","journal-title":"Dialogues Clin Neurosci"},{"issue":"3","key":"10.1016\/j.ijantimicag.2021.106380_bib0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0924-8579(99)00154-5","article-title":"Antimicrobial activity of psychotropic drugs Selective serotonin reuptake inhibitors","volume":"14","author":"Munoz-Bellido","year":"2000","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.ijantimicag.2021.106380_bib0016","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/2211556004666150520230121","article-title":"Antimicrobial Properties of Various Psychotropic Drugs Against Broad Range Microorganisms","volume":"3","author":"Kalayc","year":"2014","journal-title":"Current Psychopharmacology"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0017","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s00044-020-02507-6","article-title":"Repositioning of fluoxetine and paroxetine: study of potential antibacterial activity and its combination with ciprofloxacin","volume":"29","author":"Foletto","year":"2020","journal-title":"Med Chem Res"},{"issue":"4","key":"10.1016\/j.ijantimicag.2021.106380_bib0018","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3390\/pathogens8040228","article-title":"Vitro Activity of Sertraline, an Antidepressant, Against Antibiotic-Susceptible and Antibiotic-Resistant Helicobacter pylori Strains","volume":"8","author":"Krzyzek","year":"2019","journal-title":"Pathogen"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0019","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1093\/jac\/dkr258","article-title":"Efflux inhibition by selective serotonin reuptake inhibitors in Escherichia coli","volume":"66","author":"Bohnert","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40709-015-0028-1","article-title":"Sertraline enhances the activity of antimicrobial agents against pathogens of clinical relevance","volume":"22","author":"Ayaz","year":"2015","journal-title":"J of Biol Res-Thessaloniki"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0021","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ja.2017.78","article-title":"Insight into synergetic mechanisms of tetracycline and the selective serotonin reuptake inhibitor, sertraline, in a tetracycline-resistant strain of Escherichia coli","volume":"70","author":"Li","year":"2017","journal-title":"J Antibiot"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0022","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.micpath.2018.07.040","article-title":"New roles of fluoxetine in pharmacology: Antibacterial effect and modulation of antibiotic activity","volume":"123","author":"De Sousa","year":"2018","journal-title":"Microb Pathog"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0023","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1590\/S1517-83822010000300014","article-title":"An Investigation on In vitro and In vivo Antimicrobial Properties of the Antidepressant: Amitriptyline Hydrochloride","volume":"41","author":"Mandal","year":"2010","journal-title":"Braz J Microbiol"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0024","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00044-019-02470-x","article-title":"In vitro evaluation of the antibacterial activity of amitriptyline and its synergistic effect with ciprofloxacin, sulfamethoxazole\u2013trimethoprim, and colistin as an alternative in drug repositioning","volume":"29","author":"Machado","year":"2019","journal-title":"Med Chem Res"},{"issue":"4","key":"10.1016\/j.ijantimicag.2021.106380_bib0025","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ijantimicag.2018.06.023","article-title":"Tricyclic antidepressants inhibit Candida albicans growth and biofilm formation","volume":"52","author":"Caldara","year":"2018","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.ijantimicag.2021.106380_bib0026","doi-asserted-by":"crossref","first-page":"S301","DOI":"10.2337\/dcS13-2013","article-title":"Individualization of Antihypertensive Drug Treatment","volume":"36","author":"Mancia","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0027","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/bmj.326.7404.1427","article-title":"Value of Low Dose Combination Treatment With Blood Pressure Lowering Drugs: Analysis of 354 Randomised Trials","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ijantimicag.2021.106380_bib0028","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1574-6968.2008.01219.x","article-title":"In vitro interactions of tobramycin with various non antibiotics against Pseudomonas aeruginosa and Burkholderia cenocepacia","volume":"285","author":"Treerat","year":"2008","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0029","doi-asserted-by":"crossref","first-page":"12","DOI":"10.11648\/j.ijpc.20190501.12","article-title":"Evaluation of Amlodipine Inhibition and Antimicrobial Effects","volume":"5","author":"Yi","year":"2019","journal-title":"Int J Pharm Chem"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0030","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fmicb.2015.00330","article-title":"Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant Mycobacterium tuberculosis clinical isolates from Brazil","volume":"6","author":"Coelho","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0031","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/jac\/dkl079","article-title":"Factors influencing the intracellular activity of fluoroquinolones: a study using levofloxacin in a Staphylococcus aureus THP-1 monocyte model","volume":"57","author":"Nguyen","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.ijantimicag.2021.106380_bib0032","first-page":"215","article-title":"Betabloqueadores adren\u00e9rgicos","volume":"16","author":"Bortolotto","year":"2009","journal-title":"Rev Bras Hipertens"},{"issue":"22","key":"10.1016\/j.ijantimicag.2021.106380_bib0033","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.3390\/molecules24224104","article-title":"The Synergy of Ciprofloxacin and Carvedilol against Staphylococcus aureus \u2013 Prospects of a New Treatment Strategy?","volume":"24","author":"Zawadzka","year":"2019","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.ijantimicag.2021.106380_bib0034","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1078\/0944-5013-00204","article-title":"Antimicrobial potentiality of a new non-antibiotic: the cardiovascular drug oxyfedrine hydrochloride","volume":"158","author":"Mazumdar","year":"2003","journal-title":"Microbiol Res"},{"issue":"4","key":"10.1016\/j.ijantimicag.2021.106380_bib0035","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ijantimicag.2010.05.003","article-title":"Potential role of the cardiovascular non-antibiotic (helper compound) amlodipine in the treatment of microbial infections: scope and hope for the future","volume":"36","author":"Mazumdar","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"10.1016\/j.ijantimicag.2021.106380_bib0036","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2174\/138945006777709539","article-title":"Non-Antibiotics\": alternative therapy for the management of MDRTB and MRSA in economically disadvantaged countries","volume":"7","author":"Amaral","year":"2006","journal-title":"Curr Drug Targets"},{"issue":"1","key":"10.1016\/j.ijantimicag.2021.106380_bib0037","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/antibiotics6010003","article-title":"Thioridazine: A Non-Antibiotic Drug Highly Effective, in Combination with First Line Anti-Tuberculosis Drugs, against Any Form of Antibiotic Resistance of Mycobacterium tuberculosis Due to Its Multi-Mechanisms of Action","volume":"6","author":"Amaral","year":"2017","journal-title":"Antibiotics"},{"issue":"3","key":"10.1016\/j.ijantimicag.2021.106380_bib0038","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1128\/AAC.47.3.917-922.2003","article-title":"Clinical Concentrations of Thioridazine Kill Intracellular Multidrug-Resistant Mycobacterium tuberculosis","volume":"47","author":"Ordway","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0039","first-page":"1","article-title":"Antimycobacterial activity of five efflux pump inhibitors against Mycobacterium tuberculosis clinical isolates","author":"Li","year":"2015","journal-title":"The Journal of Antibiotics"},{"issue":"1","key":"10.1016\/j.ijantimicag.2021.106380_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189950","article-title":"Antibacterial activity of antipsychotic agentes, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity","volume":"13","author":"Nehme","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijantimicag.2021.106380_bib0041","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4172\/2161-0703.1000225","article-title":"Modulation of Antibiotic Efficacy against Klebsiella pneumoniae by Antihistaminic Drugs","volume":"5","author":"El-Banna","year":"2016","journal-title":"J Med Microb Diagn"},{"issue":"1","key":"10.1016\/j.ijantimicag.2021.106380_bib0042","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0924-8579(02)00110-3","article-title":"Intracellular activity of clinical concentrations of phenothiazines including thioridiazine against phagocytosed Staphylococcus aureus","volume":"20","author":"Ordway","year":"2002","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.ijantimicag.2021.106380_bib0043","doi-asserted-by":"crossref","first-page":"e57493","DOI":"10.1371\/journal.pone.0057493","article-title":"A comparative Analysis of In Vitro and In Vivo Efficacies of the Enantiomers of Thioridazine and Its Racemate","volume":"8","author":"Christensen","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijantimicag.2021.106380_bib0044","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1742-7843.2005.pto960105.x","article-title":"In vitro activity of phenothiazine derivatives in Enterococcus faecalis and Enterococcus faecium","volume":"96","author":"Hendricks","year":"2005","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0045","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/0028-3908(88)90006-8","article-title":"Receptor affinity, neurochemistry and behavioral charactaristics of the enantiomeres of thioridazine: evidence for different stereoselectivities at D1 and D2 receptors in rat brain","volume":"27","author":"Svendsen","year":"1988","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0046","first-page":"f3195","article-title":"Non-steroidal Anti-Inflammatory Drugs (NSAIDs)","volume":"346","author":"Day","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0047","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00228-010-0825-2","article-title":"Non-steroidal Anti-Inflammatory Drugs: Use and Co-Treatment With Potentially Interacting Medications in the Elderly","volume":"66","author":"Vandraas","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0048","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jac\/dkl486","article-title":"Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis","volume":"59","author":"Byrne","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"34","key":"10.1016\/j.ijantimicag.2021.106380_bib0049","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.5897\/AJMR2016.8179","article-title":"Evaluation of antibacterial activity of some nonsteroidal anti-inflammatory drugs against Escherichia coli causing urinary tract infection","volume":"10","author":"Ahmed","year":"2016","journal-title":"Afr J Microbiol Res"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0050","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02268-16","article-title":"Antimicrobial Effects of Antipyretics","volume":"61","author":"Zimmermann","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0051","doi-asserted-by":"crossref","first-page":"381","DOI":"10.5455\/2319-2003.ijbcp20130807","article-title":"Experimental antibacterial activity of selective cyclooxygenase antagonista","volume":"2","author":"Al-Kuraishy","year":"2013","journal-title":"Int J Basic Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0052","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3389\/fmicb.2017.00805","article-title":"Celecoxib Enhances the Efficacy of Low-Dose Antibiotic Treatment against Polymicrobial Sepsis in Mice and Clinical Isolates of ESKAPE Pathogens","volume":"8","author":"Annamanedi","year":"2017","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.ijantimicag.2021.106380_bib0053","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijantimicag.2007.04.016","article-title":"Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice","volume":"30","author":"Dutta","year":"2007","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.ijantimicag.2021.106380_bib0054","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1179\/joc.2000.12.6.509","article-title":"Antimycotic Activity and Phagocytosis Effects of Econazole in Combination with Ibuprofen Isobuthanolammonium Against Vaginal Strains","volume":"12","author":"Drago","year":"2000","journal-title":"J Chemother"},{"issue":"6","key":"10.1016\/j.ijantimicag.2021.106380_bib0055","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1080\/00958972.2016.1149819","article-title":"Synthesis, characterization and antimicrobial activity of zinc(II) ibuprofen complexes with nitrogen-based ligands","volume":"69","author":"Abu Ali","year":"2016","journal-title":"J Coord Chem"},{"issue":"2","key":"10.1016\/j.ijantimicag.2021.106380_bib0056","first-page":"175","article-title":"Screening of Analgesic, Antimicrobial, Cytotoxic and Antioxidant Activities of Metal Complexes of Indomethacin. Dhaka Univ","volume":"13","author":"Sukul","year":"2014","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0057","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147131","article-title":"The Influence of Efflux Pump Inhibitors on the Activity of Non-Antibiotic NSAIDS against Gram-Negative Rods","volume":"11","author":"Laudy","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijantimicag.2021.106380_bib0058","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/0974-777X.62880","article-title":"In vitro antibacterial activity of Ibuprofen and acetaminophen","volume":"2","author":"Hussein","year":"2010","journal-title":"J Glob Infect Dis"},{"issue":"10","key":"10.1016\/j.ijantimicag.2021.106380_bib0059","first-page":"1493","article-title":"The antibiofilm activity of Acetylsalicylic acid, Mefenamic acid, Acetaminophen against biofilms formed by P. aeruginosa and S. epidermidis","volume":"69","author":"Abidi","year":"2019","journal-title":"J Pak Med Assoc"},{"issue":"2","key":"10.1016\/j.ijantimicag.2021.106380_bib0060","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/0974-777X.62880","article-title":"In Vitro Antibacterial Activity of Ibuprofen and Acetaminophen","volume":"2","author":"Al-Janabi","year":"2010","journal-title":"J Glob Infect Dis"},{"issue":"5","key":"10.1016\/j.ijantimicag.2021.106380_bib0061","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.talanta.2011.08.034","article-title":"Analysis of Anticancer Drugs: A Review","volume":"85","author":"Nussbaumer","year":"2011","journal-title":"Talanta"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0062","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/lam.13213","article-title":"Antibacterial activity of chemotherapeutic drugs against Escherichia coli and Staphylococcus pseudintermedius","volume":"69","author":"Campbell","year":"2019","journal-title":"Letters in Applied Microbiology"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0063","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/ja.2010.64","article-title":"Antimicrobial spectrum of the antitumor agent, cisplatin","volume":"63","author":"Joyce","year":"2010","journal-title":"J Antibiot"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0064","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.3762\/bjoc.14.284","article-title":"Repurposing the anticancer drug cisplatin with the aim of developing novel Pseudomonas aeruginosa infection control agentes","volume":"14","author":"Yuan","year":"2018","journal-title":"Beilstein J Org Chem"},{"issue":"9","key":"10.1016\/j.ijantimicag.2021.106380_bib0065","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/bit.25963","article-title":"DNA-Crosslinker Cisplatin Eradicates Bacterial Persister Cells","volume":"113","author":"Chowdhury","year":"2016","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0066","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.3389\/fmicb.2019.01556","article-title":"Repurposed Antimicrobial Combination Therapy: Tobramycin-Ciprofloxacin Hybrid Augments Activity of the Anticancer Drug Mitomycin C Against Multidrug-Resistant Gram-Negative Bacteria","volume":"10","author":"Domalaon","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0067","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000057665","article-title":"Bactericidal Effect of Combinations of Antibiotic and Antineoplastic Agents against Staphylococcus aureus and Escherichia coli","volume":"48","author":"Nyhl\u00e9n","year":"2002","journal-title":"Chemotherapy"},{"issue":"2","key":"10.1016\/j.ijantimicag.2021.106380_bib0068","first-page":"1","article-title":"Antibacterial Activity of Some Antineoplastic Drugs Against Staphylococcus aureus Isolated for UTI","volume":"4","author":"Abass","year":"2008","journal-title":"J Thi-Qar University"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0069","first-page":"117","article-title":"Antimicrobial activity of selected non-antibiotics \u2013 activity of methotrexate against Staphylococcus aureus strains","volume":"57","author":"Kruszewska","year":"2000","journal-title":"Acta Pol Pharm"},{"issue":"10","key":"10.1016\/j.ijantimicag.2021.106380_bib0070","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.medcli.2017.11.030","article-title":"Statins: pros and cons","volume":"150","author":"Pinal-Fernandez","year":"2018","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0071","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1476-0711-11-13","article-title":"Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin","volume":"11","author":"Masadeh","year":"2012","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"9","key":"10.1016\/j.ijantimicag.2021.106380_bib0072","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/13880200701574992","article-title":"An in Vitro Comparative Study on the Antioxidant Activity and Determination of Antibacterial Potential of Atorvastatin and Simvastatin","volume":"45","author":"Ajith","year":"2007","journal-title":"Pharm Biol"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0073","doi-asserted-by":"crossref","unstructured":"Sankar S, Thangamalai R, Padmanaban S, Kannan P, Srinivasan MR, Arunaman CS.In-vitro synergistic antibacterial effect of atorvastatin and ampicillin against resistant Staphylococcus spp and E. coli isolated from bovine mastites. bioRxiv 2019. doi:10.1101\/695817.","DOI":"10.1101\/695817"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0074","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128098","article-title":"Statins and Antimicrobial Effects: Simvastatin as a Potential Drug against Staphylococcus aureus Biofilm","volume":"10","author":"Graziano","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ijantimicag.2021.106380_bib0075","doi-asserted-by":"crossref","first-page":"386","DOI":"10.23736\/S0026-4806.18.05705-1","article-title":"The appropriate use of proton-pump inhibitors","volume":"109","author":"Savarino","year":"2018","journal-title":"Minerva Med"},{"issue":"1","key":"10.1016\/j.ijantimicag.2021.106380_bib0076","doi-asserted-by":"crossref","first-page":"e86715","DOI":"10.1371\/journal.pone.0086715","article-title":"Effect of proton pump inhibitors on in vitro activity of tigecycline against several common clinical pathogens","volume":"9","author":"Ni","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijantimicag.2021.106380_bib0077","doi-asserted-by":"crossref","first-page":"049","DOI":"10.3831\/KPI.2019.22.006","article-title":"Effects of Omeprazole and Caffeine Alone and in Combination with Gentamicin and Ciprofloxacin Against Antibiotic Resistant Staphylococcus aureus and Escherichia coli Strains","volume":"22","author":"Bazzaz","year":"2019","journal-title":"J Pharmacopuncture"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0078","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fendo.2017.00006","article-title":"Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management","volume":"8","author":"Chaudhury","year":"2017","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.ijantimicag.2021.106380_bib0079","first-page":"220","article-title":"Study of Antimicrobial and Antioxidant potentiality of Anti-diabetic drug Metformin","volume":"2","author":"Nasrin","year":"2014","journal-title":"Int J Pharm Drug Anal"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0080","doi-asserted-by":"crossref","unstructured":"Dash AK, Behera SR, Pattanaik BK, Palo AK. Study of antimicrobial property of some hypoglycemic drugs. Chronicles of young scientists 2011;2(4):219-221. doi:10.4103\/2229-5186.93029.","DOI":"10.4103\/2229-5186.93029"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0081","first-page":"3","article-title":"In vitro and In vivo Studies of Drug-Drug Interaction between Metformin and Cefepime","volume":"6","author":"Ferdous","year":"2015","journal-title":"Pharm Anal Acta"},{"issue":"3","key":"10.1016\/j.ijantimicag.2021.106380_bib0082","article-title":"Study of Metformin Effect on Antimicrobial Property","volume":"4","author":"Meherunisa","year":"2018","journal-title":"International Archives of BioMedical And Clinical Research."},{"issue":"3","key":"10.1016\/j.ijantimicag.2021.106380_bib0083","doi-asserted-by":"crossref","first-page":"E37","DOI":"10.1111\/j.1469-0691.2011.03752.x","article-title":"The role of pharmacokinetics\/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach","volume":"8","author":"Mouton","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.ijantimicag.2021.106380_bib0084","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/jps.1167","article-title":"Pharmacokinetic\/Pharmacodynamic Studies in Drug Product Development","volume":"91","author":"Meibohm","year":"2002","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.ijantimicag.2021.106380_bib0085","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1128\/AAC.39.3.650","article-title":"Experience with a once-daily aminoglycoside program administered to 2,184 adult patients","volume":"39","author":"Nicolau","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.ijantimicag.2021.106380_bib0086","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/molecules22010114","article-title":"The Impact of Efflux Pump Inhibitors on the Activity of Selected Non-Antibiotic Medicinal Products against Gram-Negative Bacteria","volume":"22","author":"Laudy","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0087","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12917-016-0751-3","article-title":"Antimicrobial synergy between carprofen and doxycycline against methicillinresistant Staphylococcus pseudintermedius ST71","volume":"12","author":"Brochmann","year":"2016","journal-title":"BMC Veterinary Research"},{"issue":"1","key":"10.1016\/j.ijantimicag.2021.106380_bib0088","article-title":"The effect of doxepin on Bacillus subtilis and Pseudomonas aeruginosa","volume":"2","author":"Tazehkand","year":"2018","journal-title":"J Cell Sci Mut"},{"issue":"779","key":"10.1016\/j.ijantimicag.2021.106380_bib0089","first-page":"82","article-title":"Examination of Antibacterial and Antifungal Activity of Selected Non-antibiotic Products","volume":"65","author":"Kruszewska","year":"2008","journal-title":"Acta Poloniae Pharmaceutica"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0090","first-page":"71","article-title":"Efficacy of Antibacterial Activity of Antibiotics Ciprofloxacin and Gentamycin Improved with Anti Depressant Drug, Escitalopram","volume":"21","author":"Akilandeswari","year":"2013","journal-title":"Int J Pharm Sci Rev Res"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0091","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.micpath.2018.11.056","article-title":"A mechanistic approach to the in-vitro resistance modulating effects of fluoxetine against meticillin resistant Staphylococcus aureus strains","volume":"127","author":"Neto","year":"2019","journal-title":"Microb Pathog"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0092","doi-asserted-by":"crossref","DOI":"10.1590\/s2175-97902019000418089","article-title":"Synergistic effect of sertraline and disulfiram against multidrug resistant bacteria as a new alternative to drug repositioning","volume":"56","author":"Serafin","year":"2020","journal-title":"Braz J Pharm Sci"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0093","first-page":"457","article-title":"Estimulation of Antimicrobial Activity of Selected Non-Antibiotic Products","volume":"63","author":"Kruszewska","year":"2006","journal-title":"Acta Poloniae Pharmaceutica"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0094","first-page":"285","article-title":"Amlodipine: A cardiovascular drug with powerful antimicrobial property","volume":"52","author":"Kumar","year":"2003","journal-title":"Acta Microbiol Pol"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0095","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1186\/1471-2334-13-548","article-title":"Effects of a combination of amlodipine and imipenem on 42 clinical isolates of Acinetobacter baumannii obtained from a teaching hospital in Guangzhou","volume":"13","author":"Li","year":"2013","journal-title":"China. BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.ijantimicag.2021.106380_bib0096","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ijantimicag.2017.12.014","article-title":"Antibacterial activity of high concentrations of carvedilol against gram-positive and gram-negative bact\u00e9ria","volume":"51","author":"Zawadzka","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0097","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0255-0857(21)03067-X","article-title":"Evaluation of in vitro and in vivo antibacterial activity of dobutamine hydrochoride","volume":"21","author":"Sarkar","year":"2003","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0098","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0924-8579(00)00131-X","article-title":"Interaction between antibiotics and non-conventional antibiotics on bact\u00e9ria","volume":"14","author":"Gunics","year":"2000","journal-title":"I J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.ijantimicag.2021.106380_bib0099","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000151267","article-title":"Enhancement of the Antibiotic Activity against a Multiresistant Escherichia coli by Mentha arvensis L. and Chlorpromazine","volume":"54","author":"Coutinho","year":"2008","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0100","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0924-8579(03)00200-0","article-title":"Phenothiazines alter resistance of methicillin-resistant strains of Staphylococcus aureus (MRSA) to oxacillin in vitro","volume":"22","author":"Kristiansen","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0101","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/antibiotics2010058","article-title":"Role of Phenothiazines and Structurally Similar Compounds of Plant Origin in the Fight against Infections by Drug Resistant Bacteria","volume":"2","author":"Dastidar","year":"2013","journal-title":"Antibiotics"},{"issue":"3","key":"10.1016\/j.ijantimicag.2021.106380_bib0102","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1590\/S1517-83822011000300018","article-title":"In vitro Antibacterial Activity of Some Antihistaminic Belonging to Different Groups Against Multi-Drug resistant Clinical Isolates","volume":"42","author":"El-Nakeeb","year":"2011","journal-title":"Braz J Microbiol"},{"issue":"2","key":"10.1016\/j.ijantimicag.2021.106380_bib0103","doi-asserted-by":"crossref","first-page":"181e188","DOI":"10.1016\/j.resmic.2012.10.007","article-title":"Thioridazine potentiates the effect of a beta-lactam antibiotic against Staphylococcus aureus independently of mecA expression","volume":"164","author":"Poulsen","year":"2013","journal-title":"Res Microbiol"},{"issue":"4","key":"10.1016\/j.ijantimicag.2021.106380_bib0104","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijmyco.2012.09.002","article-title":"Tentative susceptibility testing breakpoint for the neuroleptic drug thioridazine, a treatment option for multi- and extensively drug resistant tuberculosis","volume":"1","author":"\u00c4ngeby","year":"2012","journal-title":"Int J Mycobacteriol"},{"issue":"12","key":"10.1016\/j.ijantimicag.2021.106380_bib0105","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.1128\/AAC.00829-13","article-title":"Thioridazine pharmacokinetic-pharmacodynamic parameters \"Wobble\" during treatment of tuberculosis: a theoretical basis for shorter-duration curative monotherapy with congeners","volume":"57","author":"Musuka","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0106","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tube.2016.02.003","article-title":"Neuroleptic drugs in the treatment of tuberculosis: Minimal inhibitory concentrations of different phenothiazines against Mycobacterium tuberculosis","volume":"98","author":"Vesenbeckh","year":"2016","journal-title":"Tuberculosis"},{"issue":"2","key":"10.1016\/j.ijantimicag.2021.106380_bib0107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149326","article-title":"Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis","volume":"11","author":"Machado","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijantimicag.2021.106380_bib0108","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2672.2009.04205.x","article-title":"The assessment of the antibacterial and antifungal activities of aspirin, EDTA and aspirin\u2013EDTA combination and their effectiveness as antibiofilm agentes","volume":"107","author":"Al-Bakri","year":"2009","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0109","doi-asserted-by":"crossref","first-page":"14658","DOI":"10.1038\/s41598-019-50746-4","article-title":"In vitro Antimicrobial Activity of Acne Drugs Against Skin-Associated Bacteria","volume":"9","author":"Blaskovich","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jgar.2017.03.012","article-title":"Title: Synergistic effect of non-steroidal anti-inflammatory drugs (NSAIDs) on antibacterial activity of cefuroxime and chloramphenicol against methicillin-resistant Staphylococcus aureus","volume":"10","author":"Chan","year":"2017","journal-title":"J Glob Antimicrob Resist"},{"issue":"3","key":"10.1016\/j.ijantimicag.2021.106380_bib0111","article-title":"Avalia\u00e7\u00e3o da atividade antibacteriana in vitro do medicamento \u00e1cido acetilsalic\u00edlico","volume":"45","author":"Mainardi","year":"2019","journal-title":"Revista Sa\u00fade (Sta. Maria)"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0112","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3389\/fmicb.2015.00750","article-title":"Repurposing celecoxib as a topical antimicrobial agente","volume":"6","author":"Thangamani","year":"2015","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.ijantimicag.2021.106380_bib0113","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijantimicag.2007.04.018","article-title":"Potential management of resistant microbial infections with a novel non-antibiotic: the anti-inflammatory drug diclofenac sodium","volume":"30","author":"Dutta","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0114","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1590\/S1517-83822004000300009","article-title":"Antimycobacterial activity of the antiinflammatory agente diclofenac sodium, and its synergism with streptomycin","volume":"35","author":"Dutta","year":"2004","journal-title":"Braz J Microbiol"},{"issue":"3","key":"10.1016\/j.ijantimicag.2021.106380_bib0115","first-page":"554","article-title":"Screening of Diclofenac for Antibacterial activity against Pathogenic Microorganisms","volume":"4","author":"Padma","year":"2015","journal-title":"Int J Adv Pharm, Biol Chem"},{"issue":"1","key":"10.1016\/j.ijantimicag.2021.106380_bib0116","first-page":"16","article-title":"Antibacterial Effect of Diclofenac Sodium on Enterococcus faecalis","volume":"10","author":"Salem-Milani","year":"2013","journal-title":"J. Dent. (Tehran)"},{"issue":"1","key":"10.1016\/j.ijantimicag.2021.106380_bib0117","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jsps.2018.08.001","article-title":"Preparation, characterization, and antibacterial activity of diclofenac-loaded chitosan nanoparticles","volume":"27","author":"Algahtani","year":"2019","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0118","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s10096-009-0739-z","article-title":"The anti-inflammatory non-antibiotic helper compound diclofenac: an antibacterial drug target","volume":"28","author":"Mazumdar","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.ijantimicag.2021.106380_bib0120","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0924-8579(03)00064-5","article-title":"Evaluation of a synergistic combination between the non-antibiotic microbicides diclofenac and trifluoperazine","volume":"21","author":"Dastidar","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0122","doi-asserted-by":"crossref","first-page":"197e205","DOI":"10.1016\/j.ejmech.2019.01.046","article-title":"Repurposing ibuprofen to control Staphylococcus aureus biofilms","volume":"166","author":"Oliveira","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"4","key":"10.1016\/j.ijantimicag.2021.106380_bib0121","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diagmicrobio.2010.03.016","article-title":"Biofilm formation by Streptococcus pneumoniae strains and effects of human serum albumin, ibuprofen, N-acetyl-L-cysteine, amoxicillin, erythromycin, and levofloxacin","volume":"67","author":"Del Prado","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0123","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-002672","article-title":"Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay","volume":"3","author":"Guzman","year":"2013","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.ijantimicag.2021.106380_bib0124","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1042\/BJ20150467","article-title":"Doxorubicin inhibits E. coli division by interacting at a novel site in FtsZ","volume":"471","author":"Panda","year":"2015","journal-title":"Biochem J"},{"issue":"2","key":"10.1016\/j.ijantimicag.2021.106380_bib0125","doi-asserted-by":"crossref","first-page":"e17369","DOI":"10.1590\/s2175-97902018000217369","article-title":"Synergistic antibacterial effect of statins with the complex {[1-(4-bromophenyl)-3-phenyltriazene N3-oxide-\u03ba2 N1,O4] (dimethylbenzylamine-\u03ba2 C1,N4)palladium(II)}","volume":"54","author":"Rampelotto","year":"2018","journal-title":"Braz J Pharm Sci"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0126","doi-asserted-by":"crossref","first-page":"16407","DOI":"10.1038\/srep16407","article-title":"Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agente","volume":"5","author":"Thangamani","year":"2015","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/j.ijantimicag.2021.106380_bib0127","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/jac\/dkm496","article-title":"Unexpected antimicrobial effect of statins","volume":"61","author":"Jerwood","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0128","first-page":"33","article-title":"Study of antimicrobial property of metformin","volume":"7","author":"Shiwanvitha","year":"2018","journal-title":"Int J Sci Res"},{"issue":"4","key":"10.1016\/j.ijantimicag.2021.106380_bib0129","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3109\/13880209.2010.519390","article-title":"antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids","volume":"49","author":"\u00d6z\u00e7elik","year":"2011","journal-title":"Pharm Biol"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0130","first-page":"3505","article-title":"In vitro Investigation of Antibacterial Activity of Drugs Used in Sedation in Intensive Care Unit","volume":"35","author":"Bostan","year":"2019","journal-title":"Acta Medica Mediterranea"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0131","first-page":"3046","article-title":"Efficacy of Chloroquine against Escherichia coli and Proteus vulgaris: An in vitro Study","volume":"2","author":"Jagadeesh","year":"2014","journal-title":"Sch J App Med Sci"},{"issue":"6","key":"10.1016\/j.ijantimicag.2021.106380_bib0132","doi-asserted-by":"crossref","first-page":"E232","DOI":"10.25011\/cim.v32i6.10657","article-title":"In vitro antibacterial activity of some systemic and topical antihistaminic preparations","volume":"32","author":"Gocmen","year":"2009","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0133","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bjan.2013.02.001","article-title":"Avalia\u00e7\u00e3o in vitro das propriedades antimicrobianas de vasopressores","volume":"64","author":"Bostan","year":"2014","journal-title":"Rev Bras Anestesiol"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0134","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3851\/IMP3173","article-title":"Antibacterial effects of antiretrovirals, potential implications for microbiome studies in HIV","volume":"23","author":"Shilaih","year":"2017","journal-title":"Antivir Ther"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0135","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s12275-016-5534-9","article-title":"Antibacterial effects of N-acetylcysteine against endodontic pathogens","volume":"54","author":"Moon","year":"2016","journal-title":"J Microb"},{"issue":"1","key":"10.1016\/j.ijantimicag.2021.106380_bib0136","doi-asserted-by":"crossref","first-page":"212","DOI":"10.21037\/jtd.2017.11.130","article-title":"In vitro effects of N-acetylcysteine alone and combined with tigecycline on planktonic cells and biofilms of Acinetobacter baumannii","volume":"10","author":"Feng","year":"2018","journal-title":"J Thorac Dis"},{"issue":"2","key":"10.1016\/j.ijantimicag.2021.106380_bib0137","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4322\/rbeb.2013.019","article-title":"N-acetylcysteine and vancomycin alone and in combination against staphylococci biofilm","volume":"29","author":"Leite","year":"2013","journal-title":"Rev Bras Eng Biom\u00e9d"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0138","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/vde.12795","article-title":"Antibacterial effect of N-acetylcysteine in combination with antimicrobials on common canine otitis externa bacterial isolates","volume":"30","author":"May","year":"2019","journal-title":"Vet Dermatol"},{"key":"10.1016\/j.ijantimicag.2021.106380_bib0139","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.micpath.2017.02.030","article-title":"N-acetylcysteine inhibits growth, adhesion and biofilm formation of Gram-positive skin pathogens","volume":"105","author":"Eroshenko","year":"2017","journal-title":"Microb Pathog"},{"issue":"24","key":"10.1016\/j.ijantimicag.2021.106380_bib0140","first-page":"5134","article-title":"Antibacterial activities of nicotine and its zinc complex","volume":"6","author":"Zaidi","year":"2012","journal-title":"Afr J Microbiol Res"},{"issue":"2","key":"10.1016\/j.ijantimicag.2021.106380_bib0141","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1213\/01.ane.0000267525.51017.b8","article-title":"The Antibacterial Activity of Tramadol Against Bacteria Associated with Infectious Complications After Local or Regional Anesthesia","volume":"105","author":"Tamanai-Shacoori","year":"2007","journal-title":"Anesth Analg"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857921001394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857921001394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:39:52Z","timestamp":1760377192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857921001394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":140,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0924857921001394"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106380","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106380"}}